# Structural Basis for D3/D4-Selective Antagonism of Piperazinylalkyl Pyrazole/Isoxazole Analogs

## TL;DR

This paper explores how certain compounds can selectively target specific dopamine receptors, which could lead to better treatments for neurological disorders.

## Contribution

The study identifies structural features that enable D4-selective antagonism through computational modeling and docking.

## Key findings

- 3D-QSAR models showed strong correlation and predictive values for D2, D3, and D4 subtypes.
- Molecular docking confirmed that non-conserved residues influence binding affinity and subtype selectivity.
- A spatial constraint in the D4 receptor's hydrophobic pocket explains its selectivity for certain ligands.

## Abstract

Dopamine D2-like receptors, including D2, D3, and D4, are members of the aminergic G protein-coupled receptor (GPCR) family and are targets for neurological disorders. The development of subtype selective ligands is important for enhanced therapeutics and reduced side effects; however, it is challenging to design and develop selective ligands owing to the high degree of sequence homology among D2-like subtypes. To gain insight into the structural basis of subtype selectivity of piperazinylalkyl pyrazole/isoxazole analogs for D2-like dopamine receptors, we carried out 3D quantitative structure–activity relationship (3D-QSAR) and molecular docking studies. The 3D-QSAR models for the D2, D3, and D4 subtypes showed robust correlation coefficients (r2) of 0.960, 0.912, and 0.946, as well as reliable predictive values (Q2) of 0.511, 0.808, and 0.560, respectively. Contour map analysis revealed key structural determinants for ligand activity, highlighting the distinct steric and electrostatic requirements for each subtype. These findings were further rationalized by molecular docking studies, which confirmed that interactions with non-conserved residues modulate binding affinity. Crucially, our analysis identified a critical structural basis for D4 subtype selectivity. This selectivity is attributed to a spatial constraint within the hydrophobic pocket formed by TMs 3, 5, and 6. This constraint restricts the orientation of bulky substituents on the 4-phenylpiperazine moiety. These findings provide actionable structural insights for the rational design of next-generation subtype-selective antagonists for D2-like dopamine receptors.